Literature DB >> 14610108

Antibodies to IFN-beta: the Danish National IFN-beta Project.

Per Soelberg Sorensen1, Christian Ross, Katja Maria Clemmesen, Klaus Bendtzen, Jette Lautrup Frederiksen, Kai Jensen, Ole Kristensen, Thor Petersen, Soren Rasmussen, Mads Ravnborg, Egon Stenager, Nils Koch-Henriksen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14610108     DOI： 10.1212/01.wnl.0000092362.44313.b6

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

1.  One-year evaluation of factors affecting the biological activity of interferon beta in multiple sclerosis patients.

Authors:  Simona Malucchi; Francesca Gilli; Marzia Caldano; Arianna Sala; Marco Capobianco; Alessia di Sapio; Letizia Granieri; Antonio Bertolotto
Journal:  J Neurol       Date:  2010-12-12       Impact factor: 4.849

Review 2.  Neutralising antibodies to interferon beta in multiple sclerosis : expert panel report.

Authors:  Hans-P Hartung; Chris Polman; Antonio Bertolotto; Florian Deisenhammer; Gavin Giovannoni; Eva Havrdova; Bernhard Hemmer; Jan Hillert; Ludwig Kappos; Bernd Kieseier; Joep Killestein; Christophe Malcus; Manuel Comabella; Andrew Pachner; Huub Schellekens; Finn Sellebjerg; Krysztof Selmaj; Per Soelberg Sorensen
Journal:  J Neurol       Date:  2007-04-24       Impact factor: 4.849

Review 3.  The Danish Multiple Sclerosis Treatment Register.

Authors:  Melinda Magyari; Nils Koch-Henriksen; Per Soelberg Sørensen
Journal:  Clin Epidemiol       Date:  2016-10-25       Impact factor: 4.790
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.